{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T01:59:11Z","timestamp":1775613551958,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00210-022-02368-3","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T06:04:01Z","timestamp":1677650641000},"page":"557-565","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating the role of intravenous pentoxifylline administration on primary percutaneous coronary intervention success rate in patients with ST-elevation myocardial infarction (PENTOS-PCI)"],"prefix":"10.1007","volume":"396","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6719-4856","authenticated-orcid":false,"given":"Hessam","family":"Kakavand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedmohammad","family":"Saadatagah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Naderian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Aghakouchakzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshad","family":"Sadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Izadi","family":"Amoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Hossein","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaser","family":"Jenab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Pourhosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Salarifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1839-3685","authenticated-orcid":false,"given":"Azita H.","family":"Talasaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"issue":"2","key":"2368_CR1","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/0735-1097(94)90285-2","volume":"24","author":"L Agati","year":"1994","unstructured":"Agati L, Voci P, Bilotta F, Luongo R, Autore C, Penco M, Iacoboni C, Fedele F, Dagianti A (1994) Influence of residual perfusion within the infarct zone on the natural history of left ventricular dysfunction after acute myocardial infarction: a myocardial contrast echocardiographic study. J Am Coll Cardiol 24(2):336\u2013342. https:\/\/doi.org\/10.1016\/0735-1097(94)90285-2","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"2368_CR2","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1161\/01.cir.101.20.2361","volume":"101","author":"T Akasaka","year":"2000","unstructured":"Akasaka T, Yoshida K, Kawamoto T, Kaji S, Ueda Y, Yamamuro A, Takagi T, Hozumi T (2000) Relation of phasic coronary flow velocity characteristics with TIMI perfusion grade and myocardial recovery after primary percutaneous transluminal coronary angioplasty and rescue stenting. Circulation 101(20):2361\u20132367. https:\/\/doi.org\/10.1161\/01.cir.101.20.2361","journal-title":"Circulation"},{"issue":"1","key":"2368_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.297.1.43","volume":"297","author":"PW Armstrong","year":"2007","unstructured":"Armstrong PW, Granger CB, Adams PX, Hamm C, Holmes D Jr, O\u2019Neill WW, Todaro TG, Vahanian A, Van de Werf F (2007) Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA 297(1):43\u201351. https:\/\/doi.org\/10.1001\/jama.297.1.43","journal-title":"JAMA"},{"issue":"1","key":"2368_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/clpt.1985.6","volume":"37","author":"B Beermann","year":"1985","unstructured":"Beermann B, Ings R, M\u00e5nsby J, Chamberlain J, McDonald A (1985) Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clin Pharmacol Ther 37(1):25\u201328. https:\/\/doi.org\/10.1038\/clpt.1985.6","journal-title":"Clin Pharmacol Ther"},{"issue":"15","key":"2368_CR5","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1161\/01.cir.99.15.1972","volume":"99","author":"MJ Claeys","year":"1999","unstructured":"Claeys MJ, Bosmans J, Veenstra L, Jorens P, De Raedt H, Vrints CJ (1999) Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation 99(15):1972\u20131977. https:\/\/doi.org\/10.1161\/01.cir.99.15.1972","journal-title":"Circulation"},{"key":"2368_CR6","doi-asserted-by":"publisher","unstructured":"Cung TT, Morel O, Cayla G, Rioufol G, Garcia-Dorado D, Angoulvant D, Bonnefoy-Cudraz E, Gu\u00e9rin P, Elbaz M, Delarche N, Coste P, Vanzetto G, Metge M, Aupetit JF, Jouve B, Motreff P, Tron C, Labeque JN, Steg PG, ... Ovize M (2015) Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med 373(11):1021-1031. https:\/\/doi.org\/10.1056\/NEJMoa1505489","DOI":"10.1056\/NEJMoa1505489"},{"key":"2368_CR7","doi-asserted-by":"publisher","unstructured":"Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) trial: a randomised controlled trial (2002) Lancet 360(9341):1189\u20131196. https:\/\/doi.org\/10.1016\/s0140-6736(02)11278-5","DOI":"10.1016\/s0140-6736(02)11278-5"},{"issue":"7","key":"2368_CR8","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/s0735-1097(02)02136-8","volume":"40","author":"DP Faxon","year":"2002","unstructured":"Faxon DP, Gibbons RJ, Chronos NA, Gurbel PA, Sheehan F (2002) The effect of blockade of the CD11\/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J Am Coll Cardiol 40(7):1199\u20131204. https:\/\/doi.org\/10.1016\/s0735-1097(02)02136-8","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2368_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.atherosclerosis.2006.11.032","volume":"196","author":"JL Fernandes","year":"2008","unstructured":"Fernandes JL, de Oliveira RTD, Mamoni RL, Coelho OR, Nicolau JC, Blotta M, Serrano CV Jr (2008) Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease\u2013a randomized placebo-controlled study. Atherosclerosis 196(1):434\u2013442. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.11.032","journal-title":"Atherosclerosis"},{"issue":"5","key":"2368_CR10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/01.cir.93.5.879","volume":"93","author":"CM Gibson","year":"1996","unstructured":"Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E (1996) TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93(5):879\u2013888. https:\/\/doi.org\/10.1161\/01.cir.93.5.879","journal-title":"Circulation"},{"issue":"1","key":"2368_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/cvr\/cvt004","volume":"98","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy DJ, Erik B\u00f8tker H, Condorelli G, Ferdinandy P, Garcia-Dorado D, Heusch G, Lecour S, van Laake LW, Madonna R, Ruiz-Meana M, Schulz R, Sluijter JP, Yellon DM, Ovize M (2013) Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 98(1):7\u201327. https:\/\/doi.org\/10.1093\/cvr\/cvt004","journal-title":"Cardiovasc Res"},{"key":"2368_CR12","doi-asserted-by":"publisher","unstructured":"Henriques JP, Zijlstra F, van't Hof AW, de Boer MJ, Dambrink JH, Gosselink M, Hoorntje JC, Suryapranata H (2003) Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 107(16):2115-2119. https:\/\/doi.org\/10.1161\/01.Cir.0000065221.06430.Ed","DOI":"10.1161\/01.Cir.0000065221.06430.Ed"},{"issue":"3","key":"2368_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1006\/jsre.1993.1141","volume":"55","author":"JW Horton","year":"1993","unstructured":"Horton JW, White DJ (1993) Free radical scavengers prevent intestinal ischemia-reperfusion-mediated cardiac dysfunction. J Surg Res 55(3):282\u2013289. https:\/\/doi.org\/10.1006\/jsre.1993.1141","journal-title":"J Surg Res"},{"issue":"2","key":"2368_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsk\u00fd P (2018) 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119\u2013177. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393","journal-title":"Eur Heart J"},{"issue":"4","key":"2368_CR15","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/fjc.0000000000000980","volume":"77","author":"H Kakavand","year":"2021","unstructured":"Kakavand H, Aghakouchakzadeh M, Coons JC, Talasaz AH (2021) Pharmacologic prevention of myocardial ischemia-reperfusion injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention. J Cardiovasc Pharmacol 77(4):430\u2013449. https:\/\/doi.org\/10.1097\/fjc.0000000000000980","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"2368_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jcin.2009.11.021","volume":"3","author":"JS Kim","year":"2010","unstructured":"Kim JS, Kim J, Choi D, Lee CJ, Lee SH, Ko YG, Hong MK, Kim BK, Oh SJ, Jeon DW, Yang JY, Cho JR, Lee NH, Cho YH, Cho DK, Jang Y (2010) Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. JACC Cardiovasc Interv 3(3):332\u2013339. https:\/\/doi.org\/10.1016\/j.jcin.2009.11.021","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"2368_CR17","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1172\/jci107898","volume":"54","author":"RA Kloner","year":"1974","unstructured":"Kloner RA, Ganote CE, Jennings RB (1974) The \u201cno-reflow\u201d phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54(6):1496\u20131508. https:\/\/doi.org\/10.1172\/jci107898","journal-title":"J Clin Invest"},{"key":"2368_CR18","doi-asserted-by":"publisher","unstructured":"Lincoff AM, Roe M, Aylward P, Galla J, Rynkiewicz A, Guetta V, Zelizko M, Kleiman N, White H, McErlean E, Erlinge D, Laine M, Dos Santos Ferreira JM, Goodman S, Mehta S, Atar D, Suryapranata H, Jensen SE, Forster T, ... Krucoff M (2014) Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial. Eur Heart J 35(37):2516-2523. https:\/\/doi.org\/10.1093\/eurheartj\/ehu177","DOI":"10.1093\/eurheartj\/ehu177"},{"issue":"10","key":"2368_CR19","first-page":"1315","volume":"32","author":"R Matzky","year":"1982","unstructured":"Matzky R, Darius H, Schr\u00f6r K (1982) The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue. Arzneimittelforschung 32(10):1315\u20131318","journal-title":"Arzneimittelforschung"},{"issue":"5","key":"2368_CR20","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1161\/hc0502.102867","volume":"105","author":"SH Rezkalla","year":"2002","unstructured":"Rezkalla SH, Kloner RA (2002) No-reflow phenomenon. Circulation 105(5):656\u2013662. https:\/\/doi.org\/10.1161\/hc0502.102867","journal-title":"Circulation"},{"key":"2368_CR21","doi-asserted-by":"publisher","unstructured":"Salhiyyah K, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA (2012) Pentoxifylline for intermittent claudication. Cochrane Database Syst Rev 1:Cd005262. https:\/\/doi.org\/10.1002\/14651858.CD005262.pub2","DOI":"10.1002\/14651858.CD005262.pub2"},{"issue":"14","key":"2368_CR22","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.jacc.2019.02.018","volume":"73","author":"Y Sandoval","year":"2019","unstructured":"Sandoval Y, Jaffe AS (2019) Type 2 myocardial infarction: JACC review topic of the week. J Am Coll Cardiol 73(14):1846\u20131860. https:\/\/doi.org\/10.1016\/j.jacc.2019.02.018","journal-title":"J Am Coll Cardiol"},{"key":"2368_CR23","doi-asserted-by":"publisher","unstructured":"Selker HP, Beshansky JR, Sheehan PR, Massaro JM, Griffith JL, D'Agostino RB, Ruthazer R, Atkins JM, Sayah AJ, Levy MK, Richards ME, Aufderheide TP, Braude DA, Pirrallo RG, Doyle DD, Frascone RJ, Kosiak DJ, Leaming JM, Van Gelder CM, ... Udelson JE (2012) Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. JAMA 307(18):1925-1933. https:\/\/doi.org\/10.1001\/jama.2012.426","DOI":"10.1001\/jama.2012.426"},{"issue":"7","key":"2368_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/000331978403500709","volume":"35","author":"A Strano","year":"1984","unstructured":"Strano A, Davi G, Avellone G, Novo S, Pinto A (1984) Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs. Angiology 35(7):459\u2013466. https:\/\/doi.org\/10.1177\/000331978403500709","journal-title":"Angiology"},{"issue":"3","key":"2368_CR25","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/s0006-291x(88)81271-3","volume":"155","author":"RM Strieter","year":"1988","unstructured":"Strieter RM, Remick DG, Ward PA, Spengler RN, Lynch JP 3rd, Larrick J, Kunkel SL (1988) Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun 155(3):1230\u20131236. https:\/\/doi.org\/10.1016\/s0006-291x(88)81271-3","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2368_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1161\/circulationaha.107.747642","volume":"118","author":"H Thiele","year":"2008","unstructured":"Thiele H, Schindler K, Friedenberger J, Eitel I, F\u00fcrnau G, Grebe E, Erbs S, Linke A, M\u00f6bius-Winkler S, Kivelitz D, Schuler G (2008) Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation 118(1):49\u201357. https:\/\/doi.org\/10.1161\/circulationaha.107.747642","journal-title":"Circulation"},{"issue":"1","key":"2368_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1540-8191.2006.00169.x","volume":"21","author":"H Ustunsoy","year":"2006","unstructured":"Ustunsoy H, Sivrikoz MC, Tarakcioglu M, Bakir K, Guldur E, Celkan MA (2006) The effects of pentoxifylline on the myocardial inflammation and ischemia-reperfusion injury during cardiopulmonary bypass. J Card Surg 21(1):57\u201361. https:\/\/doi.org\/10.1111\/j.1540-8191.2006.00169.x","journal-title":"J Card Surg"},{"issue":"7","key":"2368_CR28","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/ccd.23179","volume":"79","author":"J W\u00f6hrle","year":"2012","unstructured":"W\u00f6hrle J, Merkle N, Kunze M, Cristea E, Mehran R, Rottbauer W, Stone GW (2012) Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: the horizons-AMI CMRI substudy. Catheter Cardiovasc Interv 79(7):1083\u20131089. https:\/\/doi.org\/10.1002\/ccd.23179","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"2368_CR29","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/hrt.2007.122622","volume":"94","author":"E Wu","year":"2008","unstructured":"Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C, Kansal P, Carr JC, Holly TA, Lloyd-Jones D, Klocke FJ, Bonow RO (2008) Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 94(6):730\u2013736. https:\/\/doi.org\/10.1136\/hrt.2007.122622","journal-title":"Heart"},{"issue":"11","key":"2368_CR30","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMra071667","volume":"357","author":"DM Yellon","year":"2007","unstructured":"Yellon DM, Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357(11):1121\u20131135. https:\/\/doi.org\/10.1056\/NEJMra071667","journal-title":"N Engl J Med"},{"key":"2368_CR31","doi-asserted-by":"publisher","unstructured":"Zeymer U, Suryapranata H, Monassier JP, Opolski G, Davies J, Rasmanis G, Linssen G, Tebbe U, Schr\u00f6der R, Tiemann R, Machnig T, Neuhaus KL (2001) The Na(+)\/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J Am Coll Cardiol 38(6):1644\u20131650. https:\/\/doi.org\/10.1016\/s0735-1097(01)01608-4","DOI":"10.1016\/s0735-1097(01)01608-4"},{"issue":"2","key":"2368_CR32","doi-asserted-by":"publisher","first-page":"H832","DOI":"10.1152\/ajpheart.00178.2005","volume":"289","author":"M Zhang","year":"2005","unstructured":"Zhang M, Xu YJ, Saini HK, Turan B, Liu PP, Dhalla NS (2005) Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in ischemic-reperfused heart. Am J Physiol Heart Circ Physiol 289(2):H832-839. https:\/\/doi.org\/10.1152\/ajpheart.00178.2005","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02368-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-022-02368-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02368-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T09:04:22Z","timestamp":1677661462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-022-02368-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["2368"],"URL":"https:\/\/doi.org\/10.1007\/s00210-022-02368-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"6 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Tehran University of Medical Sciences (2018\u201303-10, IR.TUMS.MEDICINE.REC.1396.4760).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}